Ohio Public Employees Retirement System (OPERS)’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-57,218
Closed -$237K 2039
2022
Q2
$237K Buy
+57,218
New +$313K ﹤0.01% 1453

Other funds holding RYTM

Ohio Public Employees Retirement System (OPERS)'s RYTM Position: Q3 2022 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2022, closing a stake of 57,218 shares — an estimated $237K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in RYTM in Q2 2022 and held it in 1 quarter. The position peaked at $237K in Q2 2022. 101 funds tracked by Wall St. Rank hold RYTM as of Q3 2022.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Rhythm Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 57,218 Rhythm Pharmaceuticals shares in Q3 2022, an estimated $237K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Rhythm Pharmaceuticals in Q2 2022 and held it in 1 quarter.
  • Ohio Public Employees Retirement System (OPERS)'s Rhythm Pharmaceuticals position peaked at $237K in Q2 2022.
  • 101 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2022.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q3 2022, filed 15 Nov 2022.